147 related articles for article (PubMed ID: 35632399)
1. SARS-CoV-2 Antinucleocapsid Antibody Response of mRNA and Inactivated Virus Vaccines Compared to Unvaccinated Individuals.
Qaqish A; Abbas MM; Al-Tamimi M; Abbas MA; Al-Omari M; Alqassieh R
Vaccines (Basel); 2022 Apr; 10(5):. PubMed ID: 35632399
[TBL] [Abstract][Full Text] [Related]
2. The Effect of Age, Gender and Comorbidities Upon SARS-CoV-2 Spike Antibody Induction After Two Doses of Sinopharm Vaccine and the Effect of a Pfizer/BioNtech Booster Vaccine.
Farid E; Herrera-Uribe J; Stevenson NJ
Front Immunol; 2022; 13():817597. PubMed ID: 35711448
[TBL] [Abstract][Full Text] [Related]
3. Pfizer-BioNTech and Sinopharm: A Comparative Study on Post-Vaccination Antibody Titers.
Alqassieh R; Suleiman A; Abu-Halaweh S; Santarisi A; Shatnawi O; Shdaifat L; Tarifi A; Al-Tamimi M; Al-Shudifat AE; Alsmadi H; Al Sharqawi A; Alnawaiseh H; Anasweh Y; Domaidah FA; Jaber HA; Al-Zarir MR; Bsisu I
Vaccines (Basel); 2021 Oct; 9(11):. PubMed ID: 34835153
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Antibody Levels Produced by Pfizer, AstraZeneca, and Sinopharm Vaccination in COVID-19 Patients in Erbil City-Iraq.
Majed SO
Cell Mol Biol (Noisy-le-grand); 2023 Mar; 69(3):103-112. PubMed ID: 37300682
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the effectiveness and duration of anti-RBD SARS-CoV-2 IgG antibody response between different types of vaccines: Implications for vaccine strategies.
Sughayer MA; Souan L; Abu Alhowr MM; Al Rimawi D; Siag M; Albadr S; Owdeh M; Al Atrash T
Vaccine; 2022 May; 40(20):2841-2847. PubMed ID: 35397946
[TBL] [Abstract][Full Text] [Related]
6. Assessment of neutralizing antibody responses after natural SARS-CoV-2 infection and vaccination in congolese individuals.
Batchi-Bouyou AL; Djontu JC; Vouvoungui JC; Mfoutou Mapanguy CC; Lobaloba Ingoba L; Mougany JS; Boumpoutou KR; Diafouka-Kietela S; Ampa R; Ntoumi F
BMC Infect Dis; 2022 Jul; 22(1):610. PubMed ID: 35831798
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of post-vaccination immunoglobulin G antibodies and T-cell immune response after inoculation with different types and doses of SARS-CoV-2 vaccines: A retrospective cohort study.
Al-Rifai RH; Alhosani F; Abuyadek R; Atef S; Donnelly JG; Leinberger-Jabari A; Ahmed LA; Altrabulsi B; Alatoom A; Alsuwaidi AR; AbdelWareth L
Front Med (Lausanne); 2022; 9():1092646. PubMed ID: 36703898
[TBL] [Abstract][Full Text] [Related]
8. Anti-SARS-CoV-2 IgG Antibodies Post-COVID-19 or Post-Vaccination in Libyan Population: Comparison of Four Vaccines.
Ebrahim F; Tabal S; Lamami Y; Alhudiri IM; El Meshri SE; Al Dwigen S; Arfa R; Alboeshi A; Alemam HA; Abuhtna F; Altrhouni R; Milad MB; Elgriw NA; Ruaua MA; Abusrewil Z; Harroush W; Jallul M; Ali FS; Eltaib F; Elzagheid A
Vaccines (Basel); 2022 Nov; 10(12):. PubMed ID: 36560411
[TBL] [Abstract][Full Text] [Related]
9. Analysis of IgG, IgA and IgM antibodies against SARS-CoV-2 spike protein S1 in convalescent and vaccinated patients with the Pfizer-BioNTech and CanSinoBio vaccines.
Melgoza-González EA; Hinojosa-Trujillo D; Reséndiz-Sandoval M; Mata-Haro V; Hernández-Valenzuela S; García-Vega M; Bravo-Parra M; Arvizu-Flores AA; Valenzuela O; Velázquez E; Soto-Gaxiola A; Gómez-Meza MB; Pérez-Jacobo F; Villela L; Hernández J
Transbound Emerg Dis; 2022 Jul; 69(4):e734-e745. PubMed ID: 34655457
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the Roche SARS-CoV-2 Rapid Antibody Test in Samples from Vaccinated Individuals.
Hayer J; Urlaub E
Microbiol Spectr; 2022 Jun; 10(3):e0270921. PubMed ID: 35575594
[TBL] [Abstract][Full Text] [Related]
11. Humoral immune response to COVID-19 infection or vaccination among celiac disease patients.
Albatayneh E; Alabdallat Y; Kreishan E; Ayash H; Abu-Lubad M
Cent Eur J Immunol; 2022; 47(3):267-274. PubMed ID: 36817269
[TBL] [Abstract][Full Text] [Related]
12. Bimodal antibody-titer decline following BNT162b2 mRNA anti-SARS-CoV-2 vaccination in healthcare workers of the INT - IRCCS "Fondazione Pascale" Cancer Center (Naples, Italy).
Isgrò MA; Trillò G; Russo L; Tornesello AL; Buonaguro L; Tornesello ML; Miscio L; Normanno N; Bianchi AAM; Buonaguro FM; Cavalcanti E;
Infect Agent Cancer; 2022 Jul; 17(1):40. PubMed ID: 35902961
[TBL] [Abstract][Full Text] [Related]
13. Are SARS-CoV-2 Antibodies Detectable in Human Milk After Vaccination Against COVID-19?
Scaggs Huang F
J Pediatric Infect Dis Soc; 2022 Apr; 11(4):126. PubMed ID: 35394545
[TBL] [Abstract][Full Text] [Related]
14. Higher antibody responses after mRNA-based vaccine compared to inactivated vaccine against SARS-CoV-2 in Behcet's syndrome.
Ozdede A; Nohut OK; Atli Z; Tok YT; Guner S; Yilmaz E; Ucar D; Uygunoglu U; Hamuryudan V; Seyahi E
Rheumatol Int; 2022 Oct; 42(10):1741-1750. PubMed ID: 35779083
[TBL] [Abstract][Full Text] [Related]
15. Humoral response to SARS-CoV-2 COVID-19 vaccines in patients with multiple sclerosis treated with immune reconstitution therapies.
Drulovic J; Ivanovic J; Martinovic V; Tamas O; Veselinovic N; Cujic D; Gnjatovic M; Mesaros S; Pekmezovic T
Mult Scler Relat Disord; 2021 Sep; 54():103150. PubMed ID: 34298478
[TBL] [Abstract][Full Text] [Related]
16. Association between SARS-CoV-2 Symptoms, Ct Values, and Serological Response in Vaccinated and Unvaccinated Healthcare Personnel.
Farnsworth CW; O'Neil CA; Dalton C; McDonald D; Vogt L; Hock K; Arter O; Wallace MA; Muenks C; Amor M; Alvarado K; Peacock K; Jolani K; Fraser VJ; Burnham CD; Babcock HM; Budge PJ; Kwon JH
J Appl Lab Med; 2023 Sep; 8(5):871-886. PubMed ID: 37478837
[TBL] [Abstract][Full Text] [Related]
17. [Investigation of SARS-CoV-2-Specific Humoral and Cellular Immunity Values in Health Care Workers with COVID-19 Disease and Administered with COVID-19 Vaccine].
Keskin AÜ; Dalan AB; Çıragil P; Topkaya AE
Mikrobiyol Bul; 2022 Jul; 56(3):480-492. PubMed ID: 35960239
[TBL] [Abstract][Full Text] [Related]
18. Comparison of immune activation of the COVID vaccines: ChAdOx1, BNT162b2, mRNA-1273, BBIBP-CorV, and Gam-COVID-Vac from serological human samples in Hungary showed higher protection after mRNA-based immunization.
Fodor E; Olmos Calvo I; Kuten-Pella O; Hamar E; Bukva M; Madár Á; Hornyák I; Hinsenkamp A; Hetényi R; Földes F; Brigitta Z; Jakab F; Kemenesi G; Lacza Z
Eur Rev Med Pharmacol Sci; 2022 Jul; 26(14):5297-5306. PubMed ID: 35916830
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of Pfizer/BioNTech and Sinopharm COVID-19 vaccines in reducing hospital admissions in prince Hamza hospital, Jordan.
Al-Momani H; Aldajah K; Alda'ajah E; ALjafar Y; Abushawer Z
Front Public Health; 2022; 10():1008521. PubMed ID: 36211700
[TBL] [Abstract][Full Text] [Related]
20. Evaluating risk factors associated with COVID-19 infections among vaccinated people early in the U.S. vaccination campaign: an observational study of five states, January-March 2021.
Sadigh KS; Kugeler KJ; Bressler S; Massay SC; Schmoll E; Milroy L; Cavanaugh AM; Sierocki A; ; Fischer M; Nolen LD
BMC Infect Dis; 2022 Sep; 22(1):718. PubMed ID: 36050630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]